167 related articles for article (PubMed ID: 1417960)
21. Selective enhancement of hypoxic cell killing by melphalan via thiol depletion: in vitro studies with hypoxic cell sensitizers and buthionine sulfoximine.
Roizin-Towle L
J Natl Cancer Inst; 1985 Jan; 74(1):151-7. PubMed ID: 3155814
[TBL] [Abstract][Full Text] [Related]
22. Buthionine sulfoximine reduces the protective capacity of myocytes to withstand peroxide-derived free radical attack.
Le CT; Hollaar L; van der Valk EJ; van der Laarse A
J Mol Cell Cardiol; 1993 May; 25(5):519-28. PubMed ID: 8104252
[TBL] [Abstract][Full Text] [Related]
23. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
[TBL] [Abstract][Full Text] [Related]
24. Compartmentalised depletion of glutathione in cells treated with buthionine sulphoximine.
Edgren M; Révész L
Br J Radiol; 1987 Jul; 60(715):723-4. PubMed ID: 3620835
[No Abstract] [Full Text] [Related]
25. Effect of buthionine sulfoximine on the sensitivity to doxorubicin of parent and MDR tumor cell lines.
Crescimanno M; Borsellino N; Leonardi V; Flandina C; Flugy A; Rausa L; D'Alessandro N
J Chemother; 1994 Oct; 6(5):343-8. PubMed ID: 7861199
[TBL] [Abstract][Full Text] [Related]
26. Subcellular glutathione contents in isolated hepatocytes treated with L-buthionine sulfoximine.
Romero FJ; Sies H
Biochem Biophys Res Commun; 1984 Sep; 123(3):1116-21. PubMed ID: 6487323
[TBL] [Abstract][Full Text] [Related]
27. Effect of glutathione depletion by buthionine sulfoximine on rat embryonic development in vitro.
Slott VL; Hales BF
Biochem Pharmacol; 1987 Mar; 36(5):683-8. PubMed ID: 2881547
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction.
Corrales F; Ochoa P; Rivas C; Martin-Lomas M; Mato JM; Pajares MA
Hepatology; 1991 Sep; 14(3):528-33. PubMed ID: 1874498
[TBL] [Abstract][Full Text] [Related]
29. Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line.
Canada A; Herman L; Kidd K; Robertson C; Trump D
Cancer Chemother Pharmacol; 1993; 32(1):73-7. PubMed ID: 8462127
[TBL] [Abstract][Full Text] [Related]
30. The effect of glutathione on development in wild carrot suspension cultures.
Earnshaw BA; Johnson MA
Biochem Biophys Res Commun; 1985 Dec; 133(3):988-93. PubMed ID: 4084313
[TBL] [Abstract][Full Text] [Related]
31. Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers.
Ford JM; Hait WN; Matlin SA; Benz CC
Cancer Lett; 1991 Jan; 56(1):85-94. PubMed ID: 2004358
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of melphalan activity by buthionine sulfoximine and electroporation in melanoma cells.
Ongaro A; Pellati A; De Mattei M; De Terlizzi F; Rossi CR; Campana LG
Anticancer Drugs; 2015 Mar; 26(3):284-92. PubMed ID: 25514113
[TBL] [Abstract][Full Text] [Related]
33. L1210(A) mouse lymphoma cells depleted of glutathione with L-buthionine-S-R-sulfoximine proliferate in tissue culture.
Gaetjens EC; Chen P; Broome JD
Biochem Biophys Res Commun; 1984 Sep; 123(2):626-32. PubMed ID: 6487304
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamics of prolonged treatment with L,S-buthionine sulfoximine.
Malaker K; Hurwitz SJ; Bump EA; Griffith OW; Lai LL; Riese N; Coleman CN
Int J Radiat Oncol Biol Phys; 1994 May; 29(2):407-12. PubMed ID: 7910818
[TBL] [Abstract][Full Text] [Related]
35. Cellular glutathione levels and sensitivity to radiation and antineoplastic agents in human ovarian cancer.
Ozols RF; Hamilton TC; Young RC
Prog Clin Biol Res; 1988; 276():287-93. PubMed ID: 3174681
[No Abstract] [Full Text] [Related]
36. Glutathione levels in cultured heart cells. Influence of buthionine sulfoximine, an inhibitor of glutathione synthesis.
Lewko WM
Biochem Pharmacol; 1987 Jan; 36(2):219-23. PubMed ID: 3814167
[TBL] [Abstract][Full Text] [Related]
37. Effect of doxorubicin on glutathione and glutathione-dependent enzymes in cultured rat heart cells.
Paranka NS; Dorr RT
Anticancer Res; 1994; 14(5A):2047-52. PubMed ID: 7847848
[TBL] [Abstract][Full Text] [Related]
38. Effects of buthionine sulfoximine and diethyl maleate on glutathione turnover in the channel catfish.
Gallagher EP; Hasspieler BM; Di Giulio RT
Biochem Pharmacol; 1992 May; 43(10):2209-15. PubMed ID: 1350905
[TBL] [Abstract][Full Text] [Related]
39. Evidence for stimulated glutathione synthesis by phenobarbital pretreatment during an oxidative challenge in isolated hepatocytes.
Utley WS; Mehendale HM
J Biochem Toxicol; 1991; 6(2):101-13. PubMed ID: 1941896
[TBL] [Abstract][Full Text] [Related]
40. Effect of L-dopa methylester and glutathione depletion on murine B16BL6 melanoma growth in vitro.
Thrall BD; Meadows GG
J Invest Dermatol; 1991 Dec; 97(6):1073-7. PubMed ID: 1748817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
